TMEM167A and glioblastoma: We analyzed the effect of TMEM167A KD in the different GBM cells, and we observed that it only reduced amount of membrane EGFR in U87 cells (p53 wt) (Figure 4A), whereas there were no changes in the mutant p53 cell lines (Figure 4B–D).